You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

Gland Pharma Ltd Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for GLAND PHARMA LTD, and what generic and branded alternatives to GLAND PHARMA LTD drugs are available?

GLAND PHARMA LTD has one hundred and seven approved drugs.

There are two tentative approvals on GLAND PHARMA LTD drugs.

Summary for Gland Pharma Ltd

US Patents:	0
Tradenames:	97
Ingredients:	92
NDAs:	107
Drug Master File Entries:	37

Drugs and US Patents for Gland Pharma Ltd

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Gland Pharma Ltd	ZIPRASIDONE MESYLATE	ziprasidone mesylate	POWDER;INTRAMUSCULAR	211908-001	Dec 26, 2019	AP	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Gland Pharma Ltd	CARBOPROST TROMETHAMINE	carboprost tromethamine	INJECTABLE;INJECTION	217657-001	Aug 7, 2023	AP	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Gland Pharma Ltd	CLOFARABINE	clofarabine	SOLUTION;INTRAVENOUS	207831-001	Oct 31, 2018	AP	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Gland Pharma Ltd	LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER	levofloxacin	INJECTABLE;INJECTION	206908-001	Dec 30, 2020	AP	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Gland Pharma Ltd	OXALIPLATIN	oxaliplatin	INJECTABLE;INTRAVENOUS	207385-001	May 23, 2017	AP	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Gland Pharma Ltd	NEOSTIGMINE METHYLSULFATE	neostigmine methylsulfate	SOLUTION;INTRAVENOUS	212968-001	Oct 16, 2019	AP	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Gland Pharma Ltd	LEVETIRACETAM IN SODIUM CHLORIDE	levetiracetam	INJECTABLE;INTRAVENOUS	206880-003	Oct 25, 2017	AP	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Paragraph IV (Patent) Challenges for GLAND PHARMA LTD drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Injection	1 mg/mL, 50 mL vials	➤ Subscribe	2011-12-16
➤ Subscribe	Injection	100 mg/mL, 2.5 mL vials	➤ Subscribe	2007-09-24
➤ Subscribe	Injection	250 mcg/0.5 mL, 1 mL PFS	➤ Subscribe	2012-03-30

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.